Real-World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease. [PDF]
Lin LT, Lin HA, Lin SF.
europepmc +1 more source
Monoclonal antibodies in neuromyelitis optica spectrum disorder: a systematic review and meta-analysis. [PDF]
de Melo PS +4 more
europepmc +1 more source
Causal Exposures of Immune Cells in Neuromyelitis Optica Spectrum Disorders: A Mendelian Randomization Study and Flow Cytometry Analysis. [PDF]
Ren J +8 more
europepmc +1 more source
Astrocytopathy in Wernicke Encephalopathy and Neuromyelitis Optica Spectrum Disorder. Pathogenic Differences With Occasional Clinical and Neuroimaging Overlap. A Review. [PDF]
Zhang X, Kattah JC.
europepmc +1 more source
Real-World Multicenter Cohort Study of Inebilizumab vs Low-Dose Rituximab in Neuromyelitis Optica Spectrum Disorders. [PDF]
Xu Q +21 more
europepmc +1 more source
AQP4-IgG and mood disorders: Case series of neuromyelitis optica spectrum disorder. [PDF]
Xu Q +6 more
europepmc +1 more source
Myelitis-Predominant Aggressive Phenotype: Unveiling Unique Patterns of Late-Onset Neuromyelitis Optica Spectrum Disorders. [PDF]
Pu YL +15 more
europepmc +1 more source
Neuromyelitis Optica Spectrum Disorder Initially Presenting With Meningitis-Like Symptoms: A Case Report. [PDF]
Kubo Y +4 more
europepmc +1 more source
Hearing Loss in Neuromyelitis Optica Spectrum Disorder: Case Report and Systematic Review. [PDF]
Kalampokini S +6 more
europepmc +1 more source

